Researchers from Massachusetts General Hospital and Mass General Brigham, both based in Boston, used EHR data to analyze the births of 7,772 babies born in 2020 across six Massachusetts hospitals. Of those, 222 were born to mothers who tested positive for COVID-19 while pregnant.
About 6 percent of babies who were exposed to COVID-19 in the womb received a neurodevelopmental diagnosis, most of which reflected motor or speech delays, within a year, compared to 3 percent among the unexposed cohort. Risks appeared to be higher when COVID-19 was contracted during the third trimester, the study said.
Researchers were unable to assess the effect of vaccination, since the births took place before COVID-19 vaccines were available, and called for additional studies that explore how COVID-19 exposure affects fetal brain development.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
